Wilhelmus Johannes Andreas Grooten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wilhelmus Johannes Andreas Grooten has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Björn Olov Äng
School of Health and Welfare, Dalarna University, Falun, Sweden; Department of Research, Education and Innovation, Center for Clinical Research Dalarna - Uppsala University, Region Dalarna, Falun, Sweden; Department of Physical Education and Sport Science, Biomechanical and Ergonomic Laboratory, University of Thessaly, Trikala, Greece; Department of Women's and Children's Health, Physiotherapy and Behavioural Medicine, Uppsala University, Sweden
13 shared publications - Maria Hagströmer
Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Academic Primary Health Care Centre, Region Stockholm, Stockholm, Sweden
6 shared publications - Roman Peter Kuster
Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 141 83 Stockholm, Sweden
6 shared publications Christina Wiktorin
Department of Public Health Sciences, Division of Occupational Medicine, Karolinska Institutet, Stockholm, Sweden
5 shared publications- Elena Tseli
School of Health and Welfare, Dalarna University, Falun, Sweden
5 shared publications - Erika Franzén
Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden
5 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Springer Nature in Chiropractic & Manual Therapies
- Vol. 34 (1) , 60
Immediate effects of spinal manipulation, exercise therapy, and open-label placebo on lifting performance and pain in individuals with chronic non-specific back pain: a motion laboratory-based crossover randomized controlled trial
Background: Chronic non-specific back pain (CBP) is a leading cause of disability worldwide and is commonly associated with limitations in movements such as lifting. Although spinal manipulation (SMT) and exercise therapy (ET) are recommended treatments for CBP, their effects on objectively measured movement performance remain insufficiently explored. Open-label placebo (OLP) has gained attention for engaging placebo-related mechanisms ethically. This study aimed to investigate the immediate effects of SMT, ET, and OLP on lifting performance and pain in individuals with CBP, and to evaluate the add-on effects of OLP. Methods: A motion laboratory–based crossover randomized controlled trial included 50 individuals with CBP. Participants were recruited between April and July 2025 and attended a single laboratory session between September and October 2025. Participants performed lifting tasks using light and heavy loads before and after SMT, ET, and OLP interventions in randomized order. Three-dimensional motion capture was used to assess temporal, spatial, and spatiotemporal aspects of lifting performance. Subjective outcomes included pain intensity, perceived effectiveness, willingness to undergo each treatment, and treatment preference. Data were analyzed using linear mixed-effects models and functional data analysis. Results: Overall lifting performance changed to a small degree following the interventions. No significant between-group differences were observed at the primary endpoint. Significant within-group changes were observed following SMT, including altered intersegmental coordination during the light lift, characterized by a greater relative contribution of back movement early in the lifting phase, reduced thorax–pelvis tilt during the heavy lift, and reduced pain. OLP was associated with reduced thorax–pelvis tilt and increased hip and knee flexion during the light lift. Subjective evaluations did not consistently correspond to objective biomechanical changes. Conclusion: SMT, ET, and OLP demonstrated limited immediate effects on overall lifting performance in individuals with CBP. However, some within-group changes in thorax–pelvis movement and intersegmental coordination suggest that certain aspects of movement quality may respond to short-term interventions even when conventional biomechanical outcomes remain largely unchanged. The findings suggest the value of integrating subjective and objective outcomes, while advanced biomechanical analyses may provide insight into subtle movement changes in CBP. Trial registration: The trial is registered at ClinicalTrials.gov (ID NCT06891625).
- 14 October 2026
- Published by Springer Nature in Chiropractic & Manual Therapies
- Vol. 34 (1) , 60
Open AccessImmediate effects of spinal manipulation, exercise therapy, and open-label placebo on lifting performance and pain in individuals with chronic non-specific back pain: a motion laboratory-based crossover randomized controlled trial
Background: Chronic non-specific back pain (CBP) is a leading cause of disability worldwide and is commonly associated with limitations in movements such as lifting. Although spinal manipulation (SMT) and exercise therapy (ET) are recommended treatments for CBP, their effects on objectively measured movement performance remain insufficiently explored. Open-label placebo (OLP) has gained attention for engaging placebo-related mechanisms ethically. This study aimed to investigate the immediate effects of SMT, ET, and OLP on lifting performance and pain in individuals with CBP, and to evaluate the add-on effects of OLP. Methods: A motion laboratory–based crossover randomized controlled trial included 50 individuals with CBP. Participants were recruited between April and July 2025 and attended a single laboratory session between September and October 2025. Participants performed lifting tasks using light and heavy loads before and after SMT, ET, and OLP interventions in randomized order. Three-dimensional motion capture was used to assess temporal, spatial, and spatiotemporal aspects of lifting performance. Subjective outcomes included pain intensity, perceived effectiveness, willingness to undergo each treatment, and treatment preference. Data were analyzed using linear mixed-effects models and functional data analysis. Results: Overall lifting performance changed to a small degree following the interventions. No significant between-group differences were observed at the primary endpoint. Significant within-group changes were observed following SMT, including altered intersegmental coordination during the light lift, characterized by a greater relative contribution of back movement early in the lifting phase, reduced thorax–pelvis tilt during the heavy lift, and reduced pain. OLP was associated with reduced thorax–pelvis tilt and increased hip and knee flexion during the light lift. Subjective evaluations did not consistently correspond to objective biomechanical changes. Conclusion: SMT, ET, and OLP demonstrated limited immediate effects on overall lifting performance in individuals with CBP. However, some within-group changes in thorax–pelvis movement and intersegmental coordination suggest that certain aspects of movement quality may respond to short-term interventions even when conventional biomechanical outcomes remain largely unchanged. The findings suggest the value of integrating subjective and objective outcomes, while advanced biomechanical analyses may provide insight into subtle movement changes in CBP. Trial registration: The trial is registered at ClinicalTrials.gov (ID NCT06891625).
- Open Access
- 16 July 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e88887
Tailored and Interactive Mobile Telehealth Contraceptive Counseling Compared With In-Person Care: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Use of effective contraceptive methods (ECMs) reduces maternal mortality. Person-centered counseling increases uptake, but barriers to high-quality counseling persist. Telehealth may improve access to comprehensive contraceptive care, but its effectiveness remains unclear. Objective: This study assesses the effectiveness and acceptability of tailored, interactive telehealth contraceptive counseling (TECC) compared with in-person counseling. Methods: We conducted a systematic review and meta-analysis of English-language randomized controlled trials (RCTs) comparing TECC with in-person counseling for women and girls of any age and setting. We searched MEDLINE, Embase, Web of Science, and the Cochrane Library from inception through October 15, 2025. Outcomes were use of ECM less than 6 months from intervention (primary outcome); use of ECM at 6-12 months; use of long-acting reversible contraception (LARC); choice of ECM; choice of LARC; satisfaction with counseling; and method switching. Two researchers assessed risk of bias (RoB) using Cochrane RoB 2, certainty of evidence using GRADE (Grading of Recommendations Assessment, Development, and Evaluation), and performed meta-analysis using a random-effects model. The protocol was registered with PROSPERO (International Prospective Register of Systematic Reviews) a priori (CRD42023404402). No specific funding was received. Results: Eight RCTs (RoB: low, n=4; moderate, n=2; and high, n=2) and 1 cluster RCT (moderate-to-high RoB) were included in the review, with 5353 participants across all included studies. Eight studies evaluated TECC as an adjunct to in-person care (hybrid model) and 1 as a standalone model, of which 7 and 1, respectively, contributed outcome data for the meta-analyses. Certainty of evidence was low to very low. The pooled effect of 4 studies of TECC on ECM use less than 6 months showed no clear evidence of an effect (relative risk [RR] 1.10; 95% CI 0.95-1.29). The pooled effect of 4 studies of TECC on choice of ECM (RR 1.07; 95% CI 0.96-1.18) likewise showed no clear effect. The pooled effect of 4 studies of TECC on ECM use at 6-12 months showed a small but statistically significant (P=.04) effect in favor of TECC, narrowly excluding the null (RR 1.07; 95% CI 1.002-1.130). Because of high statistical and clinical heterogeneity (I2=87%-96%), results for LARC choice (2 studies) and LARC use at 0-6 months (2 studies) and 6-12 months (2 studies) were narratively described. The evidence for these outcomes was very uncertain. Narrative analysis of satisfaction across 2 studies showed no difference in effect. There were no data on method switching to support the analysis. Conclusions: Current evidence suggests, with low certainty, that adjunct TECC, when delivered alongside in-person care, shows little to no effect on contraceptive use compared with in-person care. For use at 12 months, method choice, LARC use, and satisfaction compared with in-person care, the evidence is very uncertain. Future research should prioritize adequately powered evaluations of standalone models and assess how tailoring, timing, and delivery influence effectiveness, including long-term use and method switching.
- 16 July 2026
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 14, e88887
Open AccessTailored and Interactive Mobile Telehealth Contraceptive Counseling Compared With In-Person Care: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Use of effective contraceptive methods (ECMs) reduces maternal mortality. Person-centered counseling increases uptake, but barriers to high-quality counseling persist. Telehealth may improve access to comprehensive contraceptive care, but its effectiveness remains unclear. Objective: This study assesses the effectiveness and acceptability of tailored, interactive telehealth contraceptive counseling (TECC) compared with in-person counseling. Methods: We conducted a systematic review and meta-analysis of English-language randomized controlled trials (RCTs) comparing TECC with in-person counseling for women and girls of any age and setting. We searched MEDLINE, Embase, Web of Science, and the Cochrane Library from inception through October 15, 2025. Outcomes were use of ECM less than 6 months from intervention (primary outcome); use of ECM at 6-12 months; use of long-acting reversible contraception (LARC); choice of ECM; choice of LARC; satisfaction with counseling; and method switching. Two researchers assessed risk of bias (RoB) using Cochrane RoB 2, certainty of evidence using GRADE (Grading of Recommendations Assessment, Development, and Evaluation), and performed meta-analysis using a random-effects model. The protocol was registered with PROSPERO (International Prospective Register of Systematic Reviews) a priori (CRD42023404402). No specific funding was received. Results: Eight RCTs (RoB: low, n=4; moderate, n=2; and high, n=2) and 1 cluster RCT (moderate-to-high RoB) were included in the review, with 5353 participants across all included studies. Eight studies evaluated TECC as an adjunct to in-person care (hybrid model) and 1 as a standalone model, of which 7 and 1, respectively, contributed outcome data for the meta-analyses. Certainty of evidence was low to very low. The pooled effect of 4 studies of TECC on ECM use less than 6 months showed no clear evidence of an effect (relative risk [RR] 1.10; 95% CI 0.95-1.29). The pooled effect of 4 studies of TECC on choice of ECM (RR 1.07; 95% CI 0.96-1.18) likewise showed no clear effect. The pooled effect of 4 studies of TECC on ECM use at 6-12 months showed a small but statistically significant (P=.04) effect in favor of TECC, narrowly excluding the null (RR 1.07; 95% CI 1.002-1.130). Because of high statistical and clinical heterogeneity (I2=87%-96%), results for LARC choice (2 studies) and LARC use at 0-6 months (2 studies) and 6-12 months (2 studies) were narratively described. The evidence for these outcomes was very uncertain. Narrative analysis of satisfaction across 2 studies showed no difference in effect. There were no data on method switching to support the analysis. Conclusions: Current evidence suggests, with low certainty, that adjunct TECC, when delivered alongside in-person care, shows little to no effect on contraceptive use compared with in-person care. For use at 12 months, method choice, LARC use, and satisfaction compared with in-person care, the evidence is very uncertain. Future research should prioritize adequately powered evaluations of standalone models and assess how tailoring, timing, and delivery influence effectiveness, including long-term use and method switching.
- Open Access
- 10 June 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Experiences from conducting systematic reviews of systematic reviews
This commentary discusses recent experiences from conducting two systematic reviews (SRs) of SRs. We address the strengths and limitations of conducting an SR of SRs in the field of evidence-based medicine in musculoskeletal health. Despite methodological challenges, we believe that SRs of SRs add value to the research community.
- 10 June 2026
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Open AccessExperiences from conducting systematic reviews of systematic reviews
This commentary discusses recent experiences from conducting two systematic reviews (SRs) of SRs. We address the strengths and limitations of conducting an SR of SRs in the field of evidence-based medicine in musculoskeletal health. Despite methodological challenges, we believe that SRs of SRs add value to the research community.
- Open Access
- 8 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Tailored and Interactive Mobile Telehealth Contraceptive Counseling Compared With In-Person Care: Systematic Review and Meta-Analysis of Randomized Controlled Trials (Preprint)
BACKGROUND Use of effective contraceptive methods (ECMs) reduces maternal mortality. Person-centered counseling increases uptake, but barriers to high-quality counseling persist. Telehealth may improve access to comprehensive contraceptive care, but its effectiveness remains unclear. OBJECTIVE This study assesses the effectiveness and acceptability of tailored, interactive telehealth contraceptive counseling (TECC) compared with in-person counseling. METHODS We conducted a systematic review and meta-analysis of English-language randomized controlled trials (RCTs) comparing TECC with in-person counseling for women and girls of any age and setting. We searched MEDLINE, Embase, Web of Science, and the Cochrane Library through October 15, 2025. Outcomes were use of ECM less than 6 months (primary outcome); use of ECM at 6-12 months; use of long-acting reversible contraception (LARC); choice of ECM; choice of LARC; satisfaction with counseling; and method switching. Two researchers assessed risk of bias (RoB) using Cochrane RoB 2, certainty of evidence using GRADE (Grading of Recommendations Assessment, Development, and Evaluation), and performed meta-analysis using a random-effects model. The protocol was registered with PROSPERO (International Prospective Register of Systematic Reviews) a priori (CRD42023404402). No specific funding was received. RESULTS Eight RCTs (RoB: low, n=4; moderate, n=2; and high, n=2) and 1 cluster RCT (moderate-to-high RoB) were included in the review, with 5353 participants across all included studies. Eight studies evaluated TECC as an adjunct to in-person care (hybrid model) and 1 as a standalone model, of which 7 and 1, respectively, contributed outcome data for the meta-analyses. Certainty of evidence was low to very low. The pooled effect of 4 studies of TECC on ECM use less than 6 months showed no clear evidence of an effect (relative risk [RR] 1.10; 95% CI 0.95-1.29). The pooled effect of 4 studies of TECC on choice of ECM (RR 1.07; 95% CI 0.96-1.18) likewise showed no clear effect. The pooled effect of 4 studies of TECC on ECM use at 6-12 months showed a small but statistically significant (P=.04) effect in favor of TECC, narrowly excluding the null (RR 1.07; 95% CI 1.002-1.130). Because of high statistical and clinical heterogeneity (I2=87%-96%), results for LARC choice (2 studies) and LARC use at 0-6 months (2 studies) and 6-12 months (2 studies) were narratively described. The evidence for these outcomes was very uncertain. Narrative analysis of satisfaction across 2 studies showed no difference in effect. There were no data on method switching to support the analysis. CONCLUSIONS Current evidence suggests, with low certainty, that adjunct TECC, when delivered alongside in-person care, shows little to no effect on contraceptive use compared with in-person care. For use at 12 months, method choice, LARC use, and satisfaction compared with in-person care, the evidence is very uncertain. Future research should prioritize adequately powered evaluations of standalone models and assess how tailoring, timing, and delivery influence effectiveness, including long-term use and method switching.
- 8 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTailored and Interactive Mobile Telehealth Contraceptive Counseling Compared With In-Person Care: Systematic Review and Meta-Analysis of Randomized Controlled Trials (Preprint)
BACKGROUND Use of effective contraceptive methods (ECMs) reduces maternal mortality. Person-centered counseling increases uptake, but barriers to high-quality counseling persist. Telehealth may improve access to comprehensive contraceptive care, but its effectiveness remains unclear. OBJECTIVE This study assesses the effectiveness and acceptability of tailored, interactive telehealth contraceptive counseling (TECC) compared with in-person counseling. METHODS We conducted a systematic review and meta-analysis of English-language randomized controlled trials (RCTs) comparing TECC with in-person counseling for women and girls of any age and setting. We searched MEDLINE, Embase, Web of Science, and the Cochrane Library through October 15, 2025. Outcomes were use of ECM less than 6 months (primary outcome); use of ECM at 6-12 months; use of long-acting reversible contraception (LARC); choice of ECM; choice of LARC; satisfaction with counseling; and method switching. Two researchers assessed risk of bias (RoB) using Cochrane RoB 2, certainty of evidence using GRADE (Grading of Recommendations Assessment, Development, and Evaluation), and performed meta-analysis using a random-effects model. The protocol was registered with PROSPERO (International Prospective Register of Systematic Reviews) a priori (CRD42023404402). No specific funding was received. RESULTS Eight RCTs (RoB: low, n=4; moderate, n=2; and high, n=2) and 1 cluster RCT (moderate-to-high RoB) were included in the review, with 5353 participants across all included studies. Eight studies evaluated TECC as an adjunct to in-person care (hybrid model) and 1 as a standalone model, of which 7 and 1, respectively, contributed outcome data for the meta-analyses. Certainty of evidence was low to very low. The pooled effect of 4 studies of TECC on ECM use less than 6 months showed no clear evidence of an effect (relative risk [RR] 1.10; 95% CI 0.95-1.29). The pooled effect of 4 studies of TECC on choice of ECM (RR 1.07; 95% CI 0.96-1.18) likewise showed no clear effect. The pooled effect of 4 studies of TECC on ECM use at 6-12 months showed a small but statistically significant (P=.04) effect in favor of TECC, narrowly excluding the null (RR 1.07; 95% CI 1.002-1.130). Because of high statistical and clinical heterogeneity (I2=87%-96%), results for LARC choice (2 studies) and LARC use at 0-6 months (2 studies) and 6-12 months (2 studies) were narratively described. The evidence for these outcomes was very uncertain. Narrative analysis of satisfaction across 2 studies showed no difference in effect. There were no data on method switching to support the analysis. CONCLUSIONS Current evidence suggests, with low certainty, that adjunct TECC, when delivered alongside in-person care, shows little to no effect on contraceptive use compared with in-person care. For use at 12 months, method choice, LARC use, and satisfaction compared with in-person care, the evidence is very uncertain. Future research should prioritize adequately powered evaluations of standalone models and assess how tailoring, timing, and delivery influence effectiveness, including long-term use and method switching.
- 31 October 2025
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 42 (3) , 435-449
Does exercise adherence influence outcome in knee osteoarthritis? – a secondary analysis of a superiority randomized controlled trial
The benefits of exercise in patients with knee osteoarthritis are well documented, but there is a knowledge gap regarding how exercise adherence influences outcome. This is a secondary analysis of a multicenter randomized controlled trial (n = 189). To examine associations between exercise adherence (number of treatments, exercises, repetitions, and exercise duration) and short-term clinical outcomes. Adherence was measured by number of treatments, exercises, repetitions, and cycling duration expressed as a percentage of the prescribed dose. Pearson's correlations were calculated between adherence and outcomes: knee function (Knee Injury and Osteoarthritis Outcome Score - KOOS), eight pain visual analogue scales (VAS), and quality of life (EuroQol-5 Dimension - EQ5D). Student's t-tests assessed whether adherence was associated with achieving minimal clinically important difference (MCID). Treatment attendance was 98% in both groups. The high-dose group showed significantly lower adherence for exercises (81% vs 95%; p = .003), repetitions (79% vs 96%; p < .001), and cycling (78% vs 97%; p < .001), resulting in lower total exercise adherence (78% vs 97%; p < .001). Adherence was very weakly to weakly correlated with outcomes (r = -.209 to .117). No significant differences in adherence were found between those reaching or not reaching MCID in function, pain, or quality of life, except for pain when unloading in the final week in the high-dose group (-24.8 vs -9.5; p = .022). Despite lower adherence in the high-dose group, adherence showed little association with clinical outcomes. These results suggest that high adherence to high-dose exercise may not be necessary for short-term benefit, highlighting the need for further research on optimal dosage and identifying meaningful adherence components. ClinicalTrials.gov NCT02024126. First version 2013-12-26.
- 31 October 2025
- Published by Taylor & Francis in Physiotherapy Theory and Practice
- Vol. 42 (3) , 435-449
Does exercise adherence influence outcome in knee osteoarthritis? – a secondary analysis of a superiority randomized controlled trial
The benefits of exercise in patients with knee osteoarthritis are well documented, but there is a knowledge gap regarding how exercise adherence influences outcome. This is a secondary analysis of a multicenter randomized controlled trial (n = 189). To examine associations between exercise adherence (number of treatments, exercises, repetitions, and exercise duration) and short-term clinical outcomes. Adherence was measured by number of treatments, exercises, repetitions, and cycling duration expressed as a percentage of the prescribed dose. Pearson's correlations were calculated between adherence and outcomes: knee function (Knee Injury and Osteoarthritis Outcome Score - KOOS), eight pain visual analogue scales (VAS), and quality of life (EuroQol-5 Dimension - EQ5D). Student's t-tests assessed whether adherence was associated with achieving minimal clinically important difference (MCID). Treatment attendance was 98% in both groups. The high-dose group showed significantly lower adherence for exercises (81% vs 95%; p = .003), repetitions (79% vs 96%; p < .001), and cycling (78% vs 97%; p < .001), resulting in lower total exercise adherence (78% vs 97%; p < .001). Adherence was very weakly to weakly correlated with outcomes (r = -.209 to .117). No significant differences in adherence were found between those reaching or not reaching MCID in function, pain, or quality of life, except for pain when unloading in the final week in the high-dose group (-24.8 vs -9.5; p = .022). Despite lower adherence in the high-dose group, adherence showed little association with clinical outcomes. These results suggest that high adherence to high-dose exercise may not be necessary for short-term benefit, highlighting the need for further research on optimal dosage and identifying meaningful adherence components. ClinicalTrials.gov NCT02024126. First version 2013-12-26.
- Open Access
- 28 October 2025
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 44 (1) , 1-13
Quality assessment in sickness certificates – changes over an eight-year period in Sweden and associated factors
This study investigates changes in the quality of information in sickness certificates over time, before and after the 2011 national introduction of a revised sickness certificate, and identified factors associated with certificate quality. Four experts independently assessed the quality of a total of 783 sickness certificates issued in primary care in 2004, 2009, and 2012. A Global Quality Score (GQS) was constructed by the research group, rating quality on a 10-point scale. The cut-off for high quality was set to GQS >5. The inter-rater reliability of the GQS was tested using Intra-Class Correlation and internal consistency by Pearson correlation coefficients (r). Sickness certificates issued in 2004 and 2009 were merged into one group and compared to sickness certificates in 2012. Logistic binomial regression analyses examined associations between patient-, sick leave-, and physician-related variables and GQS. The GQS demonstrated moderate to good inter-rater reliability (ICC= 0.79, 95% CI: 0.6-0.9) and good internal consistency. Certificate quality improved significantly (p < 0.001) from 3.6 (SD 1.5) in 2004/2009 to 4.7 (SD 1.2) in 2012. In 2004/2009, mental disorder or an extended length of sick leave was negatively associated with high quality. In 2012, only female sex of the patient was negatively associated with high certificate quality. While sickness certificate quality was overall low, it improved significantly after the 2011 revision of the sickness certificate. Also, diagnosis, sick leave duration, and patient's sex were factors associated with the quality and varied over time, highlighting the need for further research regarding potential remaining differences in quality of sickness certificates.
- 28 October 2025
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 44 (1) , 1-13
Open AccessQuality assessment in sickness certificates – changes over an eight-year period in Sweden and associated factors
This study investigates changes in the quality of information in sickness certificates over time, before and after the 2011 national introduction of a revised sickness certificate, and identified factors associated with certificate quality. Four experts independently assessed the quality of a total of 783 sickness certificates issued in primary care in 2004, 2009, and 2012. A Global Quality Score (GQS) was constructed by the research group, rating quality on a 10-point scale. The cut-off for high quality was set to GQS >5. The inter-rater reliability of the GQS was tested using Intra-Class Correlation and internal consistency by Pearson correlation coefficients (r). Sickness certificates issued in 2004 and 2009 were merged into one group and compared to sickness certificates in 2012. Logistic binomial regression analyses examined associations between patient-, sick leave-, and physician-related variables and GQS. The GQS demonstrated moderate to good inter-rater reliability (ICC= 0.79, 95% CI: 0.6-0.9) and good internal consistency. Certificate quality improved significantly (p < 0.001) from 3.6 (SD 1.5) in 2004/2009 to 4.7 (SD 1.2) in 2012. In 2004/2009, mental disorder or an extended length of sick leave was negatively associated with high quality. In 2012, only female sex of the patient was negatively associated with high certificate quality. While sickness certificate quality was overall low, it improved significantly after the 2011 revision of the sickness certificate. Also, diagnosis, sick leave duration, and patient's sex were factors associated with the quality and varied over time, highlighting the need for further research regarding potential remaining differences in quality of sickness certificates.
- Open Access
- 16 March 2025
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 105 (5)
Clinical Assessment of Walking Capacity in People With Parkinson Disease: Are 2 Minutes Sufficient?
Objective: Walking capacity progressively declines in people with Parkinson disease (PD), and assessment of walking is imperative for monitoring disease progression and evaluating intervention efficacy. The main aim of this study was to explore whether the 2-minute walk test (2MWT) could be substituted for the 6-minute walk test (6MWT) as a measure of walking capacity in people with PD. We also sought to investigate construct and known-groups validity of the 2MWT. Methods: A cross-sectional analysis based on data from the Supported Home Training in Everyday Life for Parkinson Disease trial was conducted in a hospital setting. Sixty-three people with idiopathic, mild to moderate PD (29 women; mean age = 69.2 years) were included. Spatiotemporal gait parameters during the 2MWT and the 6MWT were captured by wearable sensors. Linear regression was used to analyze the association between distances walked, whereas paired-samples t tests and repeated-measures analysis of variance were used to explore mean differences in gait parameters. Results: Distance walked over the 2MWT was very strongly associated with the 6MWT. Gait speed was higher during the shorter test, and several speed-related parameters significantly differed between the tests. There was a trend over the 6MWT, whereby participants performed better during the last 2 minutes of the test. Analyses revealed convergent, discriminant, and known-groups validity of the 2MWT. Conclusion: These findings suggest that the 2MWT adequately captures walking capacity among people with mild to moderate PD and demonstrates robust convergent validity and ability to discriminate between people at different levels of disease severity. Impact: The 2MWT is a sufficient and valid alternative for physical therapists who wish to assess walking capacity in people with mild to moderate PD.
- 16 March 2025
- Published by Oxford University Press (OUP) in Physical Therapy
- Vol. 105 (5)
Open AccessClinical Assessment of Walking Capacity in People With Parkinson Disease: Are 2 Minutes Sufficient?
Objective: Walking capacity progressively declines in people with Parkinson disease (PD), and assessment of walking is imperative for monitoring disease progression and evaluating intervention efficacy. The main aim of this study was to explore whether the 2-minute walk test (2MWT) could be substituted for the 6-minute walk test (6MWT) as a measure of walking capacity in people with PD. We also sought to investigate construct and known-groups validity of the 2MWT. Methods: A cross-sectional analysis based on data from the Supported Home Training in Everyday Life for Parkinson Disease trial was conducted in a hospital setting. Sixty-three people with idiopathic, mild to moderate PD (29 women; mean age = 69.2 years) were included. Spatiotemporal gait parameters during the 2MWT and the 6MWT were captured by wearable sensors. Linear regression was used to analyze the association between distances walked, whereas paired-samples t tests and repeated-measures analysis of variance were used to explore mean differences in gait parameters. Results: Distance walked over the 2MWT was very strongly associated with the 6MWT. Gait speed was higher during the shorter test, and several speed-related parameters significantly differed between the tests. There was a trend over the 6MWT, whereby participants performed better during the last 2 minutes of the test. Analyses revealed convergent, discriminant, and known-groups validity of the 2MWT. Conclusion: These findings suggest that the 2MWT adequately captures walking capacity among people with mild to moderate PD and demonstrates robust convergent validity and ability to discriminate between people at different levels of disease severity. Impact: The 2MWT is a sufficient and valid alternative for physical therapists who wish to assess walking capacity in people with mild to moderate PD.
- Open Access
- 21 November 2024
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 56, jrm36886
Exploring international classification of functioning, disability and health applicability for coding work-related disability: a study on depression and fibromyalgia in Swedish sick leave certificates
Objective: This study explores the effectiveness of using the International Classification of Functioning, Disability and Health (ICF) as a coding framework to document work-related disability information in sick leave certificates, focusing on depression and fibromyalgia in Sweden. Design: A qualitative ICF linking study was conducted, mapping information from 200 certificates per diagnosis to ICF. Methods: ICF linking rules were followed strictly. The coverage of ICF and ICF Core Sets was evaluated, proposing additional ICF categories when relevant categories were not included. Saturation of ICF categories was considered achieved if no new categories appeared in the last 5 certificates. Results: The study found high ICF coverage (85% for depression, 78% for fibromyalgia) in capturing work-related disability information. However, there was limited coverage in ICF Core Sets due to an excess of ICF categories in the Core Sets. Also, 2 additional relevant ICF categories for depression and 3 for fibromyalgia were identified. Conclusion: This study confirms that the International Classification of Functioning, Disability and Health is suitable for coding work-related disability in sick leave certificates. However, the identified limitations in ICF Core Sets highlights the need for context-specific subsets to enhance their relevance for depression and fibromyalgia in work-related disability.
- 21 November 2024
- Published by Medical Journals Sweden AB in Journal of Rehabilitation Medicine
- Vol. 56, jrm36886
Open AccessExploring international classification of functioning, disability and health applicability for coding work-related disability: a study on depression and fibromyalgia in Swedish sick leave certificates
Objective: This study explores the effectiveness of using the International Classification of Functioning, Disability and Health (ICF) as a coding framework to document work-related disability information in sick leave certificates, focusing on depression and fibromyalgia in Sweden. Design: A qualitative ICF linking study was conducted, mapping information from 200 certificates per diagnosis to ICF. Methods: ICF linking rules were followed strictly. The coverage of ICF and ICF Core Sets was evaluated, proposing additional ICF categories when relevant categories were not included. Saturation of ICF categories was considered achieved if no new categories appeared in the last 5 certificates. Results: The study found high ICF coverage (85% for depression, 78% for fibromyalgia) in capturing work-related disability information. However, there was limited coverage in ICF Core Sets due to an excess of ICF categories in the Core Sets. Also, 2 additional relevant ICF categories for depression and 3 for fibromyalgia were identified. Conclusion: This study confirms that the International Classification of Functioning, Disability and Health is suitable for coding work-related disability in sick leave certificates. However, the identified limitations in ICF Core Sets highlights the need for context-specific subsets to enhance their relevance for depression and fibromyalgia in work-related disability.
- Open Access
The Effect of Therapeutic Exercise on Body Weight Distribution, Balance, and Stifle Function in Dogs following Stifle Injury
Stifle injury is common in the companion dog population, affecting weight bearing, neuromuscular control, and balance. Therapeutic exercises after stifle injury seem to be effective, but high-quality research evaluating the effects is lacking. This randomized controlled trial evaluated the effects of a 12-week progressive therapeutic home exercise protocol on three-legged standing, targeting balance and postural- and neuromuscular control and disability in dogs with stifle injury. Thirty-three dogs with stifle injury were randomly allocated to intervention (n = 18) and control groups (n = 15), both receiving a standard rehabilitation protocol. Additionally, the intervention group received a progressive therapeutic exercise protocol. The outcome measures were static body weight distribution between hindlimbs, balance control, the canine brief pain inventory, and the Finnish canine stifle index. Both groups improved after the intervention period, but the group using the progressive therapeutic exercise protocol improved to a greater extent regarding static body weight distribution between the hindlimbs (I: median = 2.5%, IQR = 1.0–4.5; C: median = 5.5%, IQR = 3.0–8.8), pain-related functional disability (I: median = 0.0, IQR = 0.0–0.2; C: median = 0.9, IQR = 0.1–1.8), and stifle function (I: median = 25.0, IQR = 9.4–40.6; C: median = 75.0, IQR = 31.3–87.5), with intermediate to strong effects. These clinically relevant results indicate that this home exercise program can improve hindlimb function and restore neuromuscular control.
Open AccessThe Effect of Therapeutic Exercise on Body Weight Distribution, Balance, and Stifle Function in Dogs following Stifle Injury
Stifle injury is common in the companion dog population, affecting weight bearing, neuromuscular control, and balance. Therapeutic exercises after stifle injury seem to be effective, but high-quality research evaluating the effects is lacking. This randomized controlled trial evaluated the effects of a 12-week progressive therapeutic home exercise protocol on three-legged standing, targeting balance and postural- and neuromuscular control and disability in dogs with stifle injury. Thirty-three dogs with stifle injury were randomly allocated to intervention (n = 18) and control groups (n = 15), both receiving a standard rehabilitation protocol. Additionally, the intervention group received a progressive therapeutic exercise protocol. The outcome measures were static body weight distribution between hindlimbs, balance control, the canine brief pain inventory, and the Finnish canine stifle index. Both groups improved after the intervention period, but the group using the progressive therapeutic exercise protocol improved to a greater extent regarding static body weight distribution between the hindlimbs (I: median = 2.5%, IQR = 1.0–4.5; C: median = 5.5%, IQR = 3.0–8.8), pain-related functional disability (I: median = 0.0, IQR = 0.0–0.2; C: median = 0.9, IQR = 0.1–1.8), and stifle function (I: median = 25.0, IQR = 9.4–40.6; C: median = 75.0, IQR = 31.3–87.5), with intermediate to strong effects. These clinically relevant results indicate that this home exercise program can improve hindlimb function and restore neuromuscular control.
- 1 July 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (7) , eL230141
High- Versus Low-Dose Exercise Therapy for Knee Osteoarthritis
- 1 July 2023
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 176 (7) , eL230141
High- Versus Low-Dose Exercise Therapy for Knee Osteoarthritis